{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T05:43:34Z","timestamp":1784958214999,"version":"3.55.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T00:00:00Z","timestamp":1509667200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["III 41023"],"award-info":[{"award-number":["III 41023"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["OI 175068"],"award-info":[{"award-number":["OI 175068"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00404-017-4581-8","type":"journal-article","created":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T00:47:40Z","timestamp":1509670060000},"page":"495-503","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Assessment of ovarian function after chemotherapy in women with early and locally advanced breast cancer from Serbia"],"prefix":"10.1007","volume":"297","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5733-291X","authenticated-orcid":false,"given":"Emina","family":"Malisic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4529-1537","authenticated-orcid":false,"given":"Snezana","family":"Susnjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5778-5393","authenticated-orcid":false,"given":"Jelena","family":"Milovanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8975-3129","authenticated-orcid":false,"given":"Natasa","family":"Todorovic-Rakovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3513-7192","authenticated-orcid":false,"given":"Vesna","family":"Kesic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,3]]},"reference":[{"key":"4581_CR1","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/OGX.0b013e318224e97b","volume":"66","author":"RT Fleischer","year":"2011","unstructured":"Fleischer RT, Vollenhoven BJ, Weston GC (2011) The effects of chemotherapy and radiotherapy on fertility in premenopausal women. Obstet Gynecol Surv 66:248\u2013254. \n                        https:\/\/doi.org\/10.1097\/OGX.0b013e318224e97b","journal-title":"Obstet Gynecol Surv"},{"key":"4581_CR2","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/pbc.22012","volume":"53","author":"RJ Johnston","year":"2009","unstructured":"Johnston RJ, Wallace WHB (2009) Normal ovarian function and assessment of ovarian reserve in the survivor of childhood cancer. Pediatr Blood Cancer 53:296\u2013302. \n                        https:\/\/doi.org\/10.1002\/pbc.22012","journal-title":"Pediatr Blood Cancer"},{"key":"4581_CR3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1634\/theoncologist.2013-0145","volume":"19","author":"NL Henry","year":"2014","unstructured":"Henry NL, Xia R, Schott AF et al (2014) Prediction of postchemotherapy ovarian function using markers of ovarian reserve. Oncologist 19:68\u201374. \n                        https:\/\/doi.org\/10.1634\/theoncologist.2013-0145","journal-title":"Oncologist"},{"key":"4581_CR4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2174\/138161212799040420","volume":"18","author":"M Lappi","year":"2012","unstructured":"Lappi M, Borini A (2012) Fertility preservation in women after the cancer. Curr Pharm Des 18:293\u2013302","journal-title":"Curr Pharm Des"},{"key":"4581_CR5","doi-asserted-by":"publisher","first-page":"R51","DOI":"10.1530\/ERC-13-0335","volume":"21","author":"C Bozza","year":"2014","unstructured":"Bozza C, Puglisi F, Lambertini M et al (2014) Anti-Mullerian hormone: determination of ovarian reserve in early breast cancer patients. Endocr Relat Cancer 21:R51\u2013R65. \n                        https:\/\/doi.org\/10.1530\/ERC-13-0335","journal-title":"Endocr Relat Cancer"},{"key":"4581_CR6","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3109\/0284186X.2016.1155738","volume":"55","author":"A Zavos","year":"2016","unstructured":"Zavos A, Valachis A (2016) Risk of chemotherapy-induced amenorrhea in patients with breast cancer: a systematic review and meta-analysis. Acta Oncol 55:664\u2013670. \n                        https:\/\/doi.org\/10.3109\/0284186X.2016.1155738","journal-title":"Acta Oncol"},{"key":"4581_CR7","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/humrep\/16.6.1055","volume":"16","author":"A Lass","year":"2001","unstructured":"Lass A (2001) Assessment of ovarian reserve\u2014is there a role for ovarian biopsy? Hum Reprod 16:1055\u20131057","journal-title":"Hum Reprod"},{"key":"4581_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1196\/annals.1434.011","volume":"1127","author":"ME Coccia","year":"2008","unstructured":"Coccia ME, Rizzello F (2008) Ovarian reserve. Ann N Y Acad Sci 1127:27\u201330. \n                        https:\/\/doi.org\/10.1196\/annals.1434.011","journal-title":"Ann N Y Acad Sci"},{"key":"4581_CR9","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1016\/j.fertnstert.2010.03.034","volume":"93","author":"DJ Bernard","year":"2010","unstructured":"Bernard DJ, Fortin J, Wang Y, Lamba P (2010) Mechanisms of FSH synthesis: what we know, what we don\u2019t, and why you should care. Fertil Steril 93:2465\u20132485. \n                        https:\/\/doi.org\/10.1016\/j.fertnstert.2010.03.034","journal-title":"Fertil Steril"},{"key":"4581_CR10","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S1472-6483(10)61080-2","volume":"12","author":"W Vegetti","year":"2006","unstructured":"Vegetti W, Alagna F (2006) FSH and folliculogenesis: from physiology to ovarian stimulation. Reprod Biomed Online 12:684\u2013694","journal-title":"Reprod Biomed Online"},{"key":"4581_CR11","doi-asserted-by":"publisher","first-page":"468","DOI":"10.14310\/horm.2002.1632","volume":"14","author":"I Huhtaniemi","year":"2015","unstructured":"Huhtaniemi I (2015) A short evolutionary history of FSH-stimulated spermatogenesis. Hormones (Athens) 14:468\u2013478. \n                        https:\/\/doi.org\/10.14310\/horm.2002.1632","journal-title":"Hormones (Athens)"},{"key":"4581_CR12","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1055\/s-0032-1306301","volume":"44","author":"A Christensen","year":"2012","unstructured":"Christensen A, Bentley G, Cabrera R et al (2012) Hormonal regulation of female reproduction. Horm Metab Res 44:587\u2013591. \n                        https:\/\/doi.org\/10.1055\/s-0032-1306301","journal-title":"Horm Metab Res"},{"issue":"Suppl 1","key":"4581_CR13","first-page":"82","volume":"56","author":"HG Burger","year":"2001","unstructured":"Burger HG (2001) Physiological principles of endocrine replacement: estrogen. Horm Res 56(Suppl 1):82\u201385","journal-title":"Horm Res"},{"key":"4581_CR14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1385\/ENDO:29:2:209","volume":"29","author":"S Suzuki","year":"2006","unstructured":"Suzuki S, Brown CM, Wise PM (2006) Mechanisms of neuroprotection by estrogen. Endocrine 29:209\u2013216. \n                        https:\/\/doi.org\/10.1385\/ENDO:29:2:209","journal-title":"Endocrine"},{"key":"4581_CR15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nrendo.2011.224","volume":"8","author":"JA Visser","year":"2012","unstructured":"Visser JA, Schipper I, Laven JSE, Themmen APN (2012) Anti-M\u00fcllerian hormone: an ovarian reserve marker in primary ovarian insufficiency. Nat Rev Endocrinol 8:331\u2013341. \n                        https:\/\/doi.org\/10.1038\/nrendo.2011.224","journal-title":"Nat Rev Endocrinol"},{"key":"4581_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.mce.2011.05.016","volume":"359","author":"DM Robertson","year":"2012","unstructured":"Robertson DM (2012) Inhibins and activins in blood: predictors of female reproductive health? Mol Cell Endocrinol 359:78\u201384. \n                        https:\/\/doi.org\/10.1016\/j.mce.2011.05.016","journal-title":"Mol Cell Endocrinol"},{"key":"4581_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1530\/REP-12-0121","volume":"144","author":"I Ben-Aharon","year":"2012","unstructured":"Ben-Aharon I, Shalgi R (2012) What lies behind chemotherapy-induced ovarian toxicity? Reproduction 144:153\u2013163. \n                        https:\/\/doi.org\/10.1530\/REP-12-0121","journal-title":"Reproduction"},{"key":"4581_CR18","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.bpobgyn.2011.11.008","volume":"26","author":"Z Blumenfeld","year":"2012","unstructured":"Blumenfeld Z (2012) Chemotherapy and fertility. Best Pract Res Clin Obstet Gynaecol 26:379\u2013390. \n                        https:\/\/doi.org\/10.1016\/j.bpobgyn.2011.11.008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"4581_CR19","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/GRF.0b013e3181f96b54","volume":"53","author":"D Meirow","year":"2010","unstructured":"Meirow D, Biederman H, Anderson RA, Wallace WHB (2010) Toxicity of chemotherapy and radiation on female reproduction. Clin Obstet Gynecol 53:727\u2013739. \n                        https:\/\/doi.org\/10.1097\/GRF.0b013e3181f96b54","journal-title":"Clin Obstet Gynecol"},{"key":"4581_CR20","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1093\/humupd\/dmu020","volume":"20","author":"SL Broer","year":"2014","unstructured":"Broer SL, Broekmans FJM, Laven JSE, Fauser BCJM (2014) Anti-Mullerian hormone: ovarian reserve testing and its potential clinical implications. Hum Reprod Update 20:688\u2013701. \n                        https:\/\/doi.org\/10.1093\/humupd\/dmu020","journal-title":"Hum Reprod Update"},{"key":"4581_CR21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.cca.2014.07.029","volume":"437","author":"C Peluso","year":"2014","unstructured":"Peluso C, Fonseca FLA, Rodart IF et al (2014) AMH: an ovarian reserve biomarker in assisted reproduction. Clin Chim Acta 437:175\u2013182. \n                        https:\/\/doi.org\/10.1016\/j.cca.2014.07.029","journal-title":"Clin Chim Acta"},{"key":"4581_CR22","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1038\/sj.bjc.6603814","volume":"96","author":"K Lutchman Singh","year":"2007","unstructured":"Lutchman Singh K, Muttukrishna S, Stein RC et al (2007) Predictors of ovarian reserve in young women with breast cancer. Br J Cancer 96:1808\u20131816. \n                        https:\/\/doi.org\/10.1038\/sj.bjc.6603814","journal-title":"Br J Cancer"},{"key":"4581_CR23","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1080\/07357900701829777","volume":"26","author":"C Anders","year":"2008","unstructured":"Anders C, Marcom PK, Peterson B et al (2008) A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancer. Cancer Invest 26:286\u2013295. \n                        https:\/\/doi.org\/10.1080\/07357900701829777","journal-title":"Cancer Invest"},{"key":"4581_CR24","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/j.fertnstert.2007.09.048","volume":"90","author":"A Reh","year":"2008","unstructured":"Reh A, Oktem O, Oktay K (2008) Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers. Fertil Steril 90:1635\u20131639. \n                        https:\/\/doi.org\/10.1016\/j.fertnstert.2007.09.048","journal-title":"Fertil Steril"},{"key":"4581_CR25","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/cncr.25037","volume":"116","author":"B Yu","year":"2010","unstructured":"Yu B, Douglas N, Ferin MJ et al (2010) Changes in markers of ovarian reserve and endocrine function in young women with breast cancer undergoing adjuvant chemotherapy. Cancer 116:2099\u20132105. \n                        https:\/\/doi.org\/10.1002\/cncr.25037","journal-title":"Cancer"},{"key":"4581_CR26","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/cncr.24746","volume":"116","author":"HI Su","year":"2010","unstructured":"Su HI, Sammel MD, Green J et al (2010) Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors. Cancer 116:592\u2013599. \n                        https:\/\/doi.org\/10.1002\/cncr.24746","journal-title":"Cancer"},{"key":"4581_CR27","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.fertnstert.2009.03.045","volume":"94","author":"AH Partridge","year":"2010","unstructured":"Partridge AH, Ruddy KJ, Gelber S et al (2010) Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer. Fertil Steril 94:638\u2013644. \n                        https:\/\/doi.org\/10.1016\/j.fertnstert.2009.03.045","journal-title":"Fertil Steril"},{"key":"4581_CR28","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1016\/j.ejca.2013.07.014","volume":"49","author":"RA Anderson","year":"2013","unstructured":"Anderson RA, Rosendahl M, Kelsey TW, Cameron DA (2013) Pretreatment anti-M\u00fcllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer. Eur J Cancer 49:3404\u20133411. \n                        https:\/\/doi.org\/10.1016\/j.ejca.2013.07.014","journal-title":"Eur J Cancer"},{"key":"4581_CR29","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.rbmo.2014.07.008","volume":"29","author":"A-S Hamy","year":"2014","unstructured":"Hamy A-S, Porcher R, Cuvier C et al (2014) Ovarian reserve in breast cancer: assessment with anti-M\u00fcllerian hormone. Reprod Biomed Online 29:573\u2013580. \n                        https:\/\/doi.org\/10.1016\/j.rbmo.2014.07.008","journal-title":"Reprod Biomed Online"},{"key":"4581_CR30","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1007\/s00268-014-2542-y","volume":"38","author":"V Tiong","year":"2014","unstructured":"Tiong V, Rozita AM, Taib NA et al (2014) Incidence of chemotherapy-induced ovarian failure in premenopausal women undergoing chemotherapy for breast cancer. World J Surg 38:2288\u20132296. \n                        https:\/\/doi.org\/10.1007\/s00268-014-2542-y","journal-title":"World J Surg"},{"key":"4581_CR31","doi-asserted-by":"publisher","first-page":"BC19","DOI":"10.7860\/JCDR\/2016\/15933.7328","volume":"10","author":"J Bala","year":"2016","unstructured":"Bala J, Seth S, Dhankhar R, Ghalaut VS (2016) Chemotherapy: impact on anti-M\u00fcllerian hormone levels in breast carcinoma. J Clin Diagn Res 10:BC19\u2013BC21. \n                        https:\/\/doi.org\/10.7860\/JCDR\/2016\/15933.7328","journal-title":"J Clin Diagn Res"},{"key":"4581_CR32","doi-asserted-by":"publisher","first-page":"e0140842","DOI":"10.1371\/journal.pone.0140842","volume":"10","author":"GS Liem","year":"2015","unstructured":"Liem GS, Mo FKF, Pang E et al (2015) Chemotherapy-related amenorrhea and menopause in young chinese breast cancer patients: analysis on incidence, risk factors and serum hormone profiles. PLoS One 10:e0140842. \n                        https:\/\/doi.org\/10.1371\/journal.pone.0140842","journal-title":"PLoS One"},{"key":"4581_CR33","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1634\/theoncologist.2015-0044","volume":"20","author":"I Ben-Aharon","year":"2015","unstructured":"Ben-Aharon I, Granot T, Meizner I et al (2015) Long-term follow-up of chemotherapy-induced ovarian failure in young breast cancer patients: the role of vascular toxicity. Oncologist 20:985\u2013991. \n                        https:\/\/doi.org\/10.1634\/theoncologist.2015-0044","journal-title":"Oncologist"},{"key":"4581_CR34","first-page":"1087","volume":"20","author":"J-P Long","year":"2016","unstructured":"Long J-P, Wan F, Zhang F et al (2016) DTC chemotherapy regimen is associated with higher incidence of premature ovarian failure in women of reproductive age with breast cancer. Eur Rev Med Pharmacol Sci 20:1087\u20131092","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4581_CR35","doi-asserted-by":"publisher","first-page":"e66616","DOI":"10.1371\/journal.pone.0066616","volume":"8","author":"M Berliere","year":"2013","unstructured":"Berliere M, Duhoux FP, Dalenc F et al (2013) Tamoxifen and ovarian function. PLoS One 8:e66616. \n                        https:\/\/doi.org\/10.1371\/journal.pone.0066616","journal-title":"PLoS One"},{"key":"4581_CR36","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1586\/14737140.2016.1128327","volume":"16","author":"F Montemurro","year":"2016","unstructured":"Montemurro F, Del Mastro L, De Laurentiis M, Puglisi F (2016) Endocrine therapy in premenopausal women with breast cancer: a critical appraisal of current evidence. Expert Rev Anticancer Ther 16:211\u2013218. \n                        https:\/\/doi.org\/10.1586\/14737140.2016.1128327","journal-title":"Expert Rev Anticancer Ther"},{"key":"4581_CR37","doi-asserted-by":"publisher","first-page":"v8","DOI":"10.1093\/annonc\/mdv298","volume":"26","author":"E Senkus","year":"2015","unstructured":"Senkus E, Kyriakides S, Ohno S et al (2015) Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 26:v8\u2013v30. \n                        https:\/\/doi.org\/10.1093\/annonc\/mdv298","journal-title":"Ann Oncol"},{"key":"4581_CR38","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1200\/JCO.2001.19.2.343","volume":"19","author":"JG Klijn","year":"2001","unstructured":"Klijn JG, Blamey RW, Boccardo F et al (2001) Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials. J Clin Oncol 19:343\u2013353. \n                        https:\/\/doi.org\/10.1200\/JCO.2001.19.2.343","journal-title":"J Clin Oncol"},{"key":"4581_CR39","first-page":"393","volume":"8","author":"L Barbakadze","year":"2015","unstructured":"Barbakadze L, Kristesashvili J, Khonelidze N, Tsagareishvili G (2015) The correlations of anti-mullerian hormone, follicle-stimulating hormone and antral follicle count in different age groups of infertile women. Int J Fertil Steril 8:393\u2013398","journal-title":"Int J Fertil Steril"},{"key":"4581_CR40","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3346\/jkms.2015.30.3.296","volume":"30","author":"JE Lee","year":"2015","unstructured":"Lee JE, Yoon SH, Kim HO, Min EG (2015) Correlation between the serum luteinizing hormone to folliclestimulating hormone ratio and the anti-M\u00fcllerian hormone levels in normo-ovulatory women. J Korean Med Sci 30:296. \n                        https:\/\/doi.org\/10.3346\/jkms.2015.30.3.296","journal-title":"J Korean Med Sci"},{"key":"4581_CR41","doi-asserted-by":"publisher","first-page":"227","DOI":"10.4103\/0974-1208.126285","volume":"6","author":"G Rama Raju","year":"2013","unstructured":"Rama Raju G, Chavan R, Deenadayal M et al (2013) Luteinizing hormone and follicle stimulating hormone synergy: a review of role in controlled ovarian hyper-stimulation. J Hum Reprod Sci 6:227. \n                        https:\/\/doi.org\/10.4103\/0974-1208.126285","journal-title":"J Hum Reprod Sci"},{"key":"4581_CR42","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.maturitas.2009.06.007","volume":"63","author":"CB Lambalk","year":"2009","unstructured":"Lambalk CB, van Disseldorp J, de Koning CH, Broekmans FJ (2009) Testing ovarian reserve to predict age at menopause. Maturitas 63:280\u2013291. \n                        https:\/\/doi.org\/10.1016\/j.maturitas.2009.06.007","journal-title":"Maturitas"},{"key":"4581_CR43","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.fertnstert.2009.02.043","volume":"94","author":"M Rosendahl","year":"2010","unstructured":"Rosendahl M, Andersen CY, la Cour Freiesleben N et al (2010) Dynamics and mechanisms of chemotherapy-induced ovarian follicular depletion in women of fertile age. Fertil Steril 94:156\u2013166. \n                        https:\/\/doi.org\/10.1016\/j.fertnstert.2009.02.043","journal-title":"Fertil Steril"},{"key":"4581_CR44","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1093\/humrep\/del201","volume":"21","author":"RA Anderson","year":"2006","unstructured":"Anderson RA, Themmen APN, Qahtani AA et al (2006) The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Hum Reprod 21:2583\u20132592. \n                        https:\/\/doi.org\/10.1093\/humrep\/del201","journal-title":"Hum Reprod"},{"key":"4581_CR45","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10549-014-2914-x","volume":"145","author":"J Zhao","year":"2014","unstructured":"Zhao J, Liu J, Chen K et al (2014) What lies behind chemotherapy-induced amenorrhea for breast cancer patients: a meta-analysis. Breast Cancer Res Treat 145:113\u2013128. \n                        https:\/\/doi.org\/10.1007\/s10549-014-2914-x","journal-title":"Breast Cancer Res Treat"},{"key":"4581_CR46","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.fertnstert.2007.12.044","volume":"91","author":"A Badawy","year":"2009","unstructured":"Badawy A, Elnashar A, El-Ashry M, Shahat M (2009) Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study. Fertil Steril 91:694\u2013697. \n                        https:\/\/doi.org\/10.1016\/j.fertnstert.2007.12.044","journal-title":"Fertil Steril"},{"key":"4581_CR47","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1089\/jwh.2008.0857","volume":"18","author":"MEB Clowse","year":"2009","unstructured":"Clowse MEB, Behera MA, Anders CK et al (2009) Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis. J Women\u2019s Heal 18:311\u2013319. \n                        https:\/\/doi.org\/10.1089\/jwh.2008.0857","journal-title":"J Women\u2019s Heal"},{"key":"4581_CR48","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/annonc\/mdj029","volume":"17","author":"L Mastro Del","year":"2006","unstructured":"Del Mastro L, Catzeddu T, Boni L et al (2006) Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients. Ann Oncol 17:74\u201378. \n                        https:\/\/doi.org\/10.1093\/annonc\/mdj029","journal-title":"Ann Oncol"},{"key":"4581_CR49","doi-asserted-by":"publisher","first-page":"mdv374","DOI":"10.1093\/annonc\/mdv374","volume":"26","author":"M Lambertini","year":"2015","unstructured":"Lambertini M, Ceppi M, Poggio F et al (2015) Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies. Ann Oncol 26:mdv374. \n                        https:\/\/doi.org\/10.1093\/annonc\/mdv374","journal-title":"Ann Oncol"},{"key":"4581_CR50","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1056\/NEJMoa1413204","volume":"372","author":"HCF Moore","year":"2015","unstructured":"Moore HCF, Unger JM, Phillips K-A et al (2015) Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N Engl J Med 372:923\u2013932. \n                        https:\/\/doi.org\/10.1056\/NEJMoa1413204","journal-title":"N Engl J Med"},{"key":"4581_CR51","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.2147\/OTT.S95936","volume":"8","author":"YW Shen","year":"2015","unstructured":"Shen YW, Zhang XM, Lv M et al (2015) Utility of gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a systematic review and meta-analysis. Onco Targets Ther 8:3349. \n                        https:\/\/doi.org\/10.2147\/OTT.S95936","journal-title":"Onco Targets Ther"},{"key":"4581_CR52","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s10549-009-0313-5","volume":"117","author":"A Sverrisdottir","year":"2009","unstructured":"Sverrisdottir A, Nystedt M, Johansson H, Fornander T (2009) Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial. Breast Cancer Res Treat 117:561\u2013567. \n                        https:\/\/doi.org\/10.1007\/s10549-009-0313-5","journal-title":"Breast Cancer Res Treat"},{"key":"4581_CR53","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4103\/2230-8210.85575","volume":"15","author":"N Magon","year":"2011","unstructured":"Magon N (2011) Gonadotropin releasing hormone agonists: expanding vistas. Indian J Endocrinol Metab 15:261. \n                        https:\/\/doi.org\/10.4103\/2230-8210.85575","journal-title":"Indian J Endocrinol Metab"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-017-4581-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-017-4581-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-017-4581-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,21]],"date-time":"2018-01-21T23:15:26Z","timestamp":1516576526000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-017-4581-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,3]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["4581"],"URL":"https:\/\/doi.org\/10.1007\/s00404-017-4581-8","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,3]]}}}